PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. (Q27824819)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. |
scientific article |
Statements
2 references
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients (English)
Gabriel N Hortobagyi
Mien-Chie Hung
Xiaoyan Zhou
Aysegul A Sahin
Kristine S Klos
Ping Li
Brett P Monia
Nina T Nguyen
1 August 2004
Identifiers
2 references
2 references